Anticancer activity of Morinda citrifolia (noni) fruit: A review

Phytotherapy Research

Volumn 26, Issue 10, 2012, Pages 1427-1440

  Brown, Amy C ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Noni (Morinda citrifolia)

Indexed keywords

ALCOHOL; ALNONI; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAMPTOTHECIN; CISPLATIN; DAMNACANTHAL; DOXORUBICIN; ETIRACETAM; ETOPOSIDE; FLUOROURACIL; GAMMA INTERFERON; HERBACEOUS AGENT; IBUPROFEN; IMEXON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; LIPID HYDROPEROXIDE; MITOMYCIN C; MORINDA CITRIFOLIA POLYSACCHARIDE; NITRIC OXIDE; POTASSIUM; RADICAL; SUPEROXIDE; TAHITIAN NONI; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE HEPATITIS; ANOREXIA; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DNA ADDUCT; DRUG CYTOTOXICITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DYSPNEA; EHRLICH ASCITES TUMOR; EVIDENCE BASED MEDICINE; FATIGUE; FRUIT; FRUIT JUICE; HEADACHE; HEPATITIS; HUMAN; HYPERKALEMIA; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG CARCINOMA; MALAISE; MORINDA CITRIFOLIA; NAUSEA; NONHUMAN; PERITONEUM CANCER; PLANT LEAF; PLANT ROOT; REVIEW; SARCOMA; SEIZURE; SIDE EFFECT; STOMACH CANCER; SYSTEMATIC REVIEW; THORAX DISEASE; UNITED STATES; UREA NITROGEN BLOOD LEVEL; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEVERAGES; CELL LINE, TUMOR; FRUIT; HUMANS; MICE; MORINDA; PHYTOTHERAPY; RATS;

ANIMALIA; MORINDA CITRIFOLIA; MUS;

EID: 84867332650     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4595     Document Type: Review

References (111)

1. Akihisa T, Matsumoto K, Tokuda H, et al,. 2007. Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni). J Nat Prod 70: 754-757.
2. Akihisa T, Seino K, Kaneko E, et al,. 2010. Melanogenesis inhibitory activities of iridoid-, hemiterpene-, and fatty acid-glycosides from the fruits of Morinda citrifolia (Noni). J Oleo Sci 59: 49-57.
3. Alitheen NB, Manaf AA, Yeap SK, Shuhaimi M, Nordin L, Mashitoh AR,. 2010. Immunomodulatory effects of damnacanthal isolated from roots of Morinda elliptica. Pharm Biol 48: 446-452.
4. Anonymous. 2011a. Noni juice treatment for cancer. http://www. cancertutor.com/Cancer/Noni.html. Accessed May 23, 2011.
5. Anonymous. 2011b. Tahitian Noni® Original Bioactive Beverage™ glass. http://products.tni.com/united-states/english/nonistore/product/1/134/ Accessed May 23, 2011.
6. Anonymous. 2001. Noni plant may help TB. AIDS Patient Care STDS 15: 175.
7. Arpornsuwan T, Punjanon T,. 2006. Tumor cell-selective antiproliferative effect of the extract from Morinda citrifolia fruits. Phytother Res 6: 515-517.
8. Bao L, Qin L, Liu L, et al,. 2011. Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. Chem Biol Interact 194 (2-3): 97-105.
9. Basar S, Uhlenhut K, Högger P, Schöne F, Westendorf J,. 2010. Analgesic and antiinflammatory activity of Morinda citrifolia L. (Noni) fruit. Phytother Res 24: 38-42.
10. Basu S, Hazra B,. 2006. Evaluation of nitric oxide scavenging activity, in vitro and ex vivo, of selected medicinal plants traditionally used in inflammatory diseases. Phytother Res 20: 896-900.
11. Berg JT, Furusawa E,. 2007. Failure of juice or juice extract from the noni plant (Morinda citrifolia) to protect rats against oxygen toxicity. Hawaii Med J 66: 41-44.
12. Bui AK, Bacic A, Pettolino F,. 2006. Polysaccharide composition of the fruit juice of Morinda citrifolia (noni). Phytochemistry 67: 1271-1275.
13. Burrowes JD, Van Houten G,. 2005. Use of alternative medicine by patients with stage 5 chronic kidney disease. Adv Chronic Kidney Dis 3: 312-325.
14. Calzuola I, Gianfranceschi GL, Marsili V,. 2006. Comparative activity of antioxidants from wheat sprouts, Morinda citrifolia, fermented papaya and white tea. Int J Food Sci Nutr 57: 168-177.
15. Carr ME, Klotz J, Bergeron M,. 2004. Coumadin resistance and the vitamin supplement 'Noni'. Am J Hematol 77: 103.
16. Chan-Blanco Y, Vaillant F, Perez AM, Reynes M, Brillouet JM, Brat P,. 2006. The noni fruit (Morinda citrifolia L): A review of agricultural research, nutritional and therapeutic properties. J Food Comp Anal 19: 645-654.
17. Chunhieng T, Hay L, Montet D,. 2005. Detailed study of the juice composition of noni (Morinda citrifolia) fruits from Cambodia. Fruits 60: 13-24.
18. Cimanga K, Hermans N, Apers S, et al,. 2003. Complement-inhibiting iridoids from Morinda morindoides. J Nat Prod 66: 97-102.
19. Dang-Van-Ho. 1954. A basic treatment for arterial hypertension with extracts of the roots of Morinda citrifolia (Cay-Nhau). Presse Med 62: 1020-1021.
20. Dang-Van-Ho. 1955. Treatment and prevention of hypertension and its cerebral complications by total root extracts of Morinda citrifolia. Presse Med 63: 1478.
21. Deng S, West BJ, Palu K, Jensen CJ,. 2011. Determination and comparative analysis of major iridoids in different parts and cultivation sources of Morinda citrifolia. Phytochem Anal 22: 26-30.
22. Dussossoy E, Brat P, Bony E, et al,. 2011. Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). J Ethnopharmacol 133: 108-115.
23. Etkin LE, McMillen HL,. 2003. The ethnobotany of noni (Morinda citrifolia L., Rubiaceae): Dwelling in the land between la'au lapa'au and testiNONIials. Proceedings of the 2002 Hawaii noni Conference, Nelson SC (ed.). University of Hawaii at Manoa, College of Tropical Agriculture and Human Resources.
24. European Commission. 2003. Commission Decisions of 5 June 2003 authorizing the placing on the market of 'noni juice' (juice of the fruit of Morinda citrifolia L.) as a novel food ingredient under Regulation (EC) Nr. 258/97 of the European Parliament and of the Council. Official Journal of the European Union 2003; L 144/12:12.6.2003.
25. Furusawa E, Hirazumi A, Story S, Jensen J,. 2003. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) on sarcoma 180 ascites tumour in mice. Phytother Res 17: 1158-1164.
26. Gacche RN, Dhole NA,. 2011. Profile of aldose reductase inhibition, anti-cataract and free radical scavenging activity of selected medicinal plants: an attempt to standardize the botanicals for amelioration of diabetes complications. Food Chem Toxicol 49: 1806-1813.
27. Gilani AH, Mandukhail SU, Iqbal J, et al,. 2010. Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels. BMC Complement Altern Med 10: 2.
28. Handy ESC, Pukui MK, Livermore K,. 1934. Outline of Hawaiian Physical Therapeutics. Bernice P. Bishop Museum Bulletin 126. Hawaii, The Museum: Honolulu.
29. Harada S, Fujita-Hamabe W, Kamiya K, Mizushina Y, Satake T, Tokuyama S,. 2010. Morinda citrifolia fruit juice prevents ischemic neuronal damage through suppression of the development of post-ischemic glucose intolerance. J Nat Med 64: 468-473.
30. Heinicke RM,. 1985. The pharmacologically active ingredient of noni. Bull Pacific Trop Bot Garden 15: 10-14.
31. Heinicke RM,. 2001. The Xeronine System. A New Biological System. Direct Source Publishing: Lachine, QC, Canada.
32. Heinicke R,. United States Patent # 4,543,212, September 24, 1985. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p= 1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=13&f=G&l=50&co1= AND&d=PTXT&s1=4409144&OS=4409144&RS=4409144. Accessed May 23, 2011.
33. Hemwimol S, Pavasant P, Shotipruk A,. 2006. Ultrasound-assisted extraction of anthraquinones from roots of Morinda citrifolia. Ultrason Sonochem Ultrason Sonochem 13: 543-548.
34. Hirazumi A, Furusawa E,. 1999. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 13: 380-387.
35. Hirazumi A, Furusawa E, Chou SC, Hokama Y,. 1994. Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc West Pharmacol Soc 37: 145-146.
36. Hirazumi A, Furusawa E, Chou SC, Hokama Y,. 1996. Immunomodulation contributes to the anticancer activity of Morinda citrifolia (noni) fruit juice. Proc West Pharmacol Soc 39: 7-9.
37. Hornick CA, Myers A, Sadowska-Krowicka H, Anthony CT, Woltering EA,. 2003. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni). Angiogenesis 6: 143-149.
38. Horsfall AU, Olabiyi O, Aiyegbusi A, Noronha CC, Okanlawon AO,. 2008. Morinda citrifolia fruit juice augments insulin action in Sprague-Dawley rats with experimentally induced diabetes. Nig Q J Hosp Med 18: 162-165.
39. Issell BF, Gotay C, Pagano I, Franke A,. 2005. Quality of life measures in a phase I trial of noni. J Clin Oncol ASCO Annual Meeting Proc 23 (16S): 8217.
40. Jainkittivong A, Butsarakamruha T, Langlais RP,. 2009. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108: 394-398.
41. Kamata M, Wu RP, An DS, et al,. 2006. Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. Biochem Biophys Res Commun 348: 1101-1106.
42. Kamiya K, Hamabe W, Harada S, Murakami R, Tokuyama S, Satake T,. 2008. Chemical constituents of Morinda citrifolia roots exhibit hypoglycemic effects in streptozotocin-induced diabetic mice. Biol Pharm Bull 31: 935-938.
43. Kamiya K, Tanaka Y, Endang H, Umar M, Satake T,. 2005. New anthraquinone and iridoid from the fruits of Morinda citrifolia. Chem Pharm Bull(Tokyo) 53: 1597-1599.
44. Kinghorn AD, Chai HB, Sung CK, Keller WJ,. 2011. The classical drug discovery approach to defining bioactive constituents of botanicals. Fitoterapia 82: 71-79.
45. La Barre J, Hans M, Hans MJ,. 1961. Apropos of the hypotensive, diuretic and tranquilizing properties of purified extracts of Morinda. Bull Acad R Med Belg 1: 567-581.
46. Langford J, Doughty A, Wang M, Clayton L, Babich M,. 2004. Effects of Morinda citrifolia on quality of life and auditory function in postmenopausal women. J Altern Complement Med 10: 737-739.
47. Lee CH, Wang JD, Chen PC,. 2010. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 19 (7): 708-714.
48. Li J, Stickel SL, Bouton-Verville H, et al,. 2008a. Fermented Noni exudate (fNE): a mediator between immune system and anti-tumor activity. Oncol Rep 20: 1505-1509.
49. Li N, Wang HM, Guo SH, Lin X, Zheng LP, Wang L,. 2008b. Protection of apoptosis of osteoblast cultured in vitro by Morinda root polysaccharide. Zhongguo Gu Shang 21: 39-41.
50. Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z,. 2001. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 61: 5749-5756.
51. López-Cepero Andrada JM, Lerma Castilla S, Fernández Olvera MD, Amaya Vidal A,. 2007. Hepatotoxicity caused by a Noni (Morinda citrifolia) preparation. Rev Esp Enferm Dig 2099: 179-181.
52. Lv L, Chen H, Ho CT, Sang S,. 2011. Chemical components of the roots of Noni (Morinda citrifolia) and their cytotoxic effects. Fitoterapia 82: 704-708.
53. Mahattanadul S, Ridtitid W, Nima S, Phdoongsombut N, Ratanasuwon P, Kasiwong S,. 2010. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. J Ethnopharmacol 134: 243-250.
54. Mandukhail SU, Aziz N, Gilani AH,. 2010. Studies on antidyslipidemic effects of Morinda citrifolia (Noni) fruit, leaves and root extracts. Lipids Health Dis 9: 88.
55. Mathivanan N, Surendiran G, Srinivasan K, Malrvizhi K,. 2006. Morinda pubescens JE Smith (Morinda tinctoria Roxb) fruit extract accelerates wound healing in rats. J Med Food 9: 591-593.
56. McClatchey W,. 2002. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (rubiaceae). Integr Cancer Ther 1: 110-120.
57. McKoy ML, Thomas EA, Simon OR,. 2002. Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia (noni). Proc West Pharmacol Soc 45: 76-78.
58. Millonig G, Stadlmann S, Vogel W,. 2005. Herbal hepatotoxicity: acute hepatitis caused by a noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 4: 445-447.
59. Mpiana PT, Tshibangu DS, Shetonde OM, Ngbolua KN,. 2007. In vitro antidrepanocytary activity (anti-sickle cell anemia) of some Congolese plants. Phytomedicine 14: 192-195.
60. Mueller BA, Scott MK, Sowinski KM, Prag KA,. 2000. Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis 35: 310-312.
61. Nandhasri P, Kumar Pawa K, Kaewtubtim J, Jeamchanya C, Jansom C, Sattaponpun C,. 2005. Nutraceutical properties of Thai 'Yor', Morinda citrifolia and 'Noni' juice extract. Songklanakarin J Sci Technol 27 (Suppl. 2): 579-586.
62. Nayak BS, Isitor GN, Maxwell A, Bhogadi V, Ramdath DD,. 2007. Wound-healing activity of Morinda citrifolia fruit juice on diabetes-induced rats. J Wound Care 16: 83-86.
63. Nayak BS, Marshall JR, Isitor G, Adogwa A,. 2011. Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats. Evid Based Complement Alternat Med 2011: 875293.
64. Nayak S, Mengi S,. 2010. Immunostimulant activity of noni (Morinda citrifolia) on T and B lymphocytes. Pharm Biol 48: 724-731.
65. Nayak BS, Sandiford S, Maxwell A,. 2009. Evaluation of the wound-healing activity of ethanolic extract of Morinda citrifolia L. leaf. Evid Based Complement Alternat Med 6: 351-356.
66. Nelson S, Elevitch CR,. 2006. Noni: 2006. The Complete Guide for Consumers and Growers. Permanent Agriculture Resources: Holualoa, HI.
67. Nerurkar PV, Nishioka A, Eck PO, Johns LM, Volper E, Nerurkar VR,. 2011. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. Br J Nutr 20: 1-11.
68. Nualsanit T, Rojanapanthu P, Gritsanapan W, Lee SH, Lawson D, Baek SJ,. 2011. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells. J Nutr Biochem [Epub ahead of print]
69. 3-soluble phase and its main active component, damnacanthal, isolated from the root of Morinda citrifolia. Biol Pharm Bull 34: 103-107.
70. Owen PL, Martineau LC, Caves D, Haddad PS, Matainaho T, Johns T,. 2008. Consumption of guava (Psidium guajava L) and noni (Morinda citrifolia L) may protect betel quid-chewing Papua New Guineans against diabetes. Asia Pac J Clin Nutr 17: 635-643.
71. Palu A, Deng S, West B, Jensen J,. 2009. Xanthine oxidase inhibiting effects of noni (Morinda citrifolia) fruit juice. Phytother Res 23: 1790-1791.
72. Palu AK, Kim AH, West BJ, Deng S, Jensen J, White L,. 2008. The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action. J Ethnopharmacol 115: 502-506.
73. Palu A, Su C, Zhou BN, West B, Jensen J,. 2010. Wound healing effects of noni (Morinda citrifolia L.) leaves: a mechanism involving its PDGF/A2A receptor ligand binding and promotion of wound closure. Phytother Res 24: 1437-1441.
74. Pawlus AD, Kinghorn DA,. 2007. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J Pharm Pharmacol 59: 1587-1609.
75. Pawlus AD, Su BN, Keller WJ, Kinghorn AD,. 2005. An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni). J Nat Prod 68: 1720-1722.
76. Potterat O, Hamburger M,. 2007. Morinda citrifolia (Noni) fruit-phytochemistry, pharmacology, safety. Planta Med 73: 191-199.
77. Prapaitrakool S, Itharat A,. 2010. Morinda citrifolia Linn. for prevention of postoperative nausea and vomiting. J Med Assoc Thai 93 (Suppl 7): S204-S209.
78. Saludes JP, Garson MJ, Franzblau SG, Aguinaldo AM,. 2002. Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn. (Rubiaceae). Phytother Res 16: 683-685.
79. Samoylenko V, Zhao J, Dunbar DC, Khan IA, Rushing JW, Muhammad I,. 2006. New constituents from noni (Morinda citrifolia) fruit juice. J Agric Food Chem 54: 6398-6402.
80. Sang S, Liu G, He K, et al,. 2003. New unusual iridoids from the leaves of noni (Morinda citrifolia L.) show inhibitory effect on ultraviolet B-induced transcriptional activator protein-1 (AP-1) activity. Bioorg Med Chem 11: 2499-2502.
81. Serafini MR, Santos RC, GuimarÃes AG, et al,. 2011. Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. J Med Food 14: 1159-1166.
82. Shotipruk A, Kiatsongserm J, Pavasant P, Goto M, Sasaki M,. 2004. Pressurized hot water extraction of anthraquinones from the roots of Morinda citrifolia. Biotechnol Prog 20: 1872-1875.
83. Siddiqui BS, Sattar FA, Begum S, Gulzar T, Ahmad F,. 2006. New anthraquinones from the stem of Morinda citrifolia Linn. Nat Prod Res 20: 1136-1144.
84. Solomon N., 2003. Cancer: How and Why Tahitian Noni Juice Helps in Treatment and Prevention and Noni: Nature's Gift To Cancer Patients. Direct Source Publishing: Lachine, QC, Canada.
85. Song HS, Park SH, Ko MS, Jeong JM, Sohn UD, Sim SS,. 2010. Morinda citrifolia inhibits both cytosolic Ca-dependent phospholipase A(2) and secretory Ca-dependent phospholipase A(2). Korean J Physiol Pharmacol 14: 163-167.
86. Stadlbauer V, Fickert P, Lackner C, et al,. 2005. Hepatotoxicity of NONI juice: report of two cases. World J Gastroenterol 11: 4758-4760.
87. Stadlbauer V, Weiss S, Payer F, Stauber RE,. 2008. Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with Morinda citrifolia (noni). Am J Gastroenterol 103: 2406-2407.
88. Stalman M, Koskamp AM, Luderer R, et al,. 2003. Regulation of anthraquinone biosynthesis in cell cultures of Morinda citrifolia. J Plant Physiol 160: 607-614.
89. Stoner GD, Wang LS, Seguin C, et al,. 2010. Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats. Pharm Res 27: 1138-1145.
90. Su BN, Pawlus AD, Jung HA, Keller WJ, McLaughlin JL, Kinghorn AD,. 2005. Chemical constituents of the fruits of Morinda citrifolia (noni) and their antioxidant activity. J Nat Prod 68: 592-595.
91. Takashima J, Ikeda Y, Komiyama K, Hayashi M, Kishida A, Ohsaki A,. 2007. New constituents from the leaves of Morinda citrifolia. Chem Pharm Bull(Tokyo) 55: 343-345.
92. Taşkin EI, Akgün-Dar K, Kapucu A, et al,. 2009. Apoptosis-inducing effects of Morinda citrifolia L. and doxorubicin on the Ehrlich ascites tumor in Balb-c mice. Cell Biochem Funct 27: 542-546.
93. Thani W, Vallisuta O, Siripong P, Ruangwises N,. 2010. Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J Trop Med Public Health 41: 482-489.
94. Vickers A,. 2002. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 20: 1069-1079.
95. Wallack EM, Callon R,. 2004. Liver injury associated with the beta-interferons for MS. Neurology 63: 1142-1143.
96. Wang G, He QW, Feng T, Liu JK,. 2011. Two new phenylpropanoids and one propanoate from Morinda citrifolia. J Asian Nat Prod Res 13: 238-241.
97. Wang M, Kikuzaki H, Csiszar K, et al,. 1999. Novel trisaccharide fatty acid ester identified from the fruits of Morinda citrifolia (noni). J Agric Food Chem 47: 4880-4882.
98. Wang M, Kikuzaki H, Jin Y, et al,. 2000. Novel glycosides from noni (Morinda citrifolia). J Nat Prod 63: 1182-1183.
99. Wang MY, Lutfiyya MN, Weidenbacher-Hoper V, Anderson G, Su CX, West BJ,. 2009a. Antioxidant activity of noni juice in heavy smokers. Chem Cent J 3: 13.
100. Wang MY, Peng L, Lutfiyya MN, Henley E, Weidenbacher-Hoper V, Anderson G,. 2009b. Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts. Nutr Cancer 61: 634-639.
101. Wang MY, Su C,. 2001. Cancer preventive effect of Morinda citrifolia (noni). Ann N Y Acad Sci 952: 161-168.
102. Wang MY, West BJ, Jensen CJ, et al,. 2002. Morinda citrifolia (noni): a literature review and recent advances in noni research. Acta Pharmacol Sin 23: 1127-1141.
103. West BJ, Jensen CJ, Westendorf J,. 2006a. Noni juice is not hepatotoxic. World J Gastroenterol 12: 3616-3619.
104. West BJ, Jensen CJ, Westendorf J, White LD,. 2006b. A safety review of noni fruit juice. J Food Sci 71: R100-R106.
105. West BJ, Su CX, Jensen CJ,. 2009a. Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit. J Toxicol Sci 34: 581-585.
106. West BJ, White LD, Jensen CJ, Palu AK,. 2009b. A double-blind clinical safety study of noni fruit juice. Pac Health Dialog 15: 21-32.
107. Westendorf J, Effenberger K, Iznaguen H, Basa S,. 2007. Toxicological and analytical investigations of noni (Morinda citrifolia) fruit juice. J Agric Food Chem 55: 529-537.
108. Wong DK,. 2004. Are immune responses pivotal to cancer patient's long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J 63: 182-184.
109. Yu EL, Sivagnanam M, Ellis L, Huang JS,. 2011. Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni Berry) juice in a 14-year-old boy. J Pediatr Gastroenterol Nutr 52: 222-224.
110. Yuce B, Gulberg V, Diebold J, Gerbes AL,. 2006. Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion 73: 167-170.
111. Zhang X, Li J, Wong DK, Wagner TE, Wei Y,. 2009. Fermented Noni Exudate-treated dendritic cells directly stimulate B lymphocyte proliferation and differentiation. Oncol Rep 21: 1147-1152.